Ehave, Inc. (EHVVF)

[sweet crude]

EHVVF interview coming!

Alfred Farrington, the CTO of Ehave $EHVVF, will be conducting an interview to discuss #MetaHealthU, and its ability to give patients back ownership of their #healthcare data.

Alfred Farrington, the CTO of Ehave $EHVVF, will be conducting an interview to discuss #MetaHealthU, and its ability to give patients back ownership of their #healthcare data. pic.twitter.com/g9jgBD8tk8

— Ehaveinc $EHVVF (@Ehaveinc1) December 7, 2022

....rocket only just getting fueled up

[greenwillow]

dog chit will always be dog chit

EHVVF

[PennyPrestige]

.007 and MOVING! Loving this!!!

[sweet crude]

+48% to .007

[PennyPrestige]

EHVVF Ludlow Research projects bullish outlook!

https://ludlowresearch.com/ehvvf-bullish-outlook-mental-health-crisis/

[sweet crude]

Stock at key breakout point

This could suddenly make run for .01+ here

[sweet crude]

NEWS OUT!

https://finance.yahoo.com/news/ehave-shareholder-ceo-ben-kaplan-130000012.html

MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan.

Dear Fellow Shareholders

As 2022 draws to a close, many of us will reflect on a year that saw global economic activity experiencing a broad-based and sharper-than-expected slowdown, increased inflation higher than we have seen in several decades, and higher interest rates. Despite these challenges and many others, I am very proud of our Ehave team's accomplishments in advancing our business plan. Our team executed several vital acquisitions, expanded our research capabilities, and realized many more achievements in our effort to continue to build on our strong foundation.

At the outset, I would like to provide an update on the triangular merger between our publicly traded Mycotopia Therapies (OTC: TPIA) subsidiary, Ei.Ventures, and PSLY.com. The $380 million transaction is structured to close when PSLY.com receives approval for trading on NASDAQ. We are following the procedures for this process as set forth by NASDAQ and the SEC. All parties involved are committed to completing the transaction. This transaction is important to Ehave shareholders because Ehave owns approximately 9,793,754 shares of Mycotopia Therapies. I expect to provide additional updates on this transaction and how it will affect our Ehave shareholders in the near future.

KetaDASH

I want to highlight several significant milestones our Ehave team has achieved in 2022. In February, Ehave purchased 100% of Rejuv IV, a mobile IV therapy provider in the San Francisco Bay Area. Rejuv IV became KetaDASH, a wholly owned subsidiary of Ehave, Inc. KetaDASH provides mobile Ketamine treatments for treatment-resistant depression, anxiety, PTSD, and other conditions, as well as IV infusions with fluids, essential vitamins, minerals, and electrolytes to enhance the health and wellness of its patients. After an initial telemedicine visit, a team of experienced physicians, therapists, and nurses administer every KetaDASH treatment in the patient's home, office, or mobile location. This innovative service departs from in-clinic intravenous, treatment, or unsupervised telehealth models to an at-home ketamine administration with telehealth and in-person medical supervision.

A typical KetaDASH experience incorporates a prescribing doctor, a nurse for administration and monitoring, and psychotherapists for integration, all from the comfort of the patient's home. Our KetaDASH team is pioneering efforts in precision medicine through Ehave’s partnership with Entheon Biomedical Corp.’s (CSE: ENBI) (OTCQB: ENTBF) HaluGen Life Sciences division. Our KetaDASH subsidiary is one of the first psychedelic companies to test patients with HaluGen’s expanded psychedelics genetic testing panel. This panel analyzes a series of relevant DNA biomarkers and utilizes pre-screening mental health surveys in order to provide insights into an individual's risk and potential for adverse reactions with the use of ketamine. Ehave's KetaDASH subsidiary is fully operational in Sacramento and San Francisco.

KetaDASH Miami

In June, Ehave took delivery of its first mobile KetaDASH unit, a custom high-end medical van utilizing KetaDASH's software platform. The KetaDASH Mobile Unit was specifically designed to focus on the efficacy of the treatment in a relaxed setting with the patient’s safety and comfort in mind. At the present time, KetaDASH is focusing on health, wellness, and mental health in the Miami area. KetaDASH currently does not offer ketamine treatments in Miami, but plans to start offering them in the first half of 2023.

KetaDASH Miami currently offers IV infusions with fluids, essential vitamins, minerals, and electrolytes to enhance the health and wellness of its patients. These infusions include IV Drip Detox and Hangover Cures, IV Vitamin Therapy for Pain Management, IV Hydration Therapy for Health & Wellness, and IV Therapy for Athletic Advantage and Fitness Recovery. Every infusion is administered by a qualified health care professional to ensure the safety of our patients.

Follow KetaDASH on Instagram at www.instagram.com/ketadash.usa.

MetaHealthU

MetaHealthU provides patients with a way to integrate providers, create troves of usable data for researchers, and clinicians to improve the care our nation's health system provides to its patients, providing a platform for precision health and giving patients ownership of their data. MetaHealthU focuses on interoperability, population health, and data ownership, and it has created a system that will work by providing patients the opportunity to own their health data.

We reached a milestone of 600 new users on our MetaHealthU platform during the last half of the year. The new users have found tremendous success with the platform and have compiled usable data on specific medical conditions like erectile dysfunction and fatigue. Many of these users have also used our mobile services in KetaDASH Miami.

Our Ehave team developed MetaHealthU as a powerful mobile application platform that empowers individuals to take complete control of their health and their healthcare data. With MetaHealthU, users can securely track all their health data from wearables, Electronic Health Records Systems (EHRs), doctors, and medical labs. The app is available for iOS 11.0 or later and Android. It includes a "digital file cabinet" for medical records. Users can log into their patient portals on various healthcare systems and medical labs and download their medical records in the digital file cabinet. Its features include easy-to-use navigation and search capabilities for users to collect, file, and tag their medical records on a mobile device. More information on MetaHealthU, as well as a free download of the app, can be found at https://apps.apple.com/us/app/metahealthu/id1600512401.

MetaHealthYuru

MetaHealthYuru is a personal mental health monitor that screens for early signs of mental health conditions, such as stress and depression. MetaHealthYuru uses voice analysis to screen for early signs of mental health conditions using a speech-based AI technology. Our MetaHealthYuru platform could potentially predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. This is accomplished by using vocal biomarkers to recognize your real emotional state and mood while tracking your mental health. Our technology can help detect and monitor subtle changes in the mental state by assessing individuals more frequently and objectively than the assessments used today. MetaHealthYuru can track your emotions and mood, analyze your mental state, and suggest potential treatments available for improving your mental well-being.

2023 and Beyond

In 2022 our Ehave team focused its efforts on developing our existing projects. We started the year with a large number and developed suitable metrics to gauge which ones will benefit the most from our resources. Moving forward, we intend to unlock the value created with our Mycotopia Therapies subsidiary and some of the company’s other investments. We also intend to focus our efforts on expanding our KetaDASH and MetaHealthU subsidiaries to propel Ehave into 2023 and beyond.

[greenwillow]

Ludlow who? Lololol

Dog chit

[sweet crude]

Stock wildly undervalued here

Ehave $EHVVF move into Healthcare Data Management opens them up to multi-billion health data analytics market, with big upside potential from current price $0.004

Recession proof industry

Ehave $EHVVF move into Healthcare Data Management opens them up to multi-billion health data analytics market, with big upside potential from current price $0.004

Recession proof industry$SENS $OPK $OPGN $NDRA $LMDX $GSTC $CLNV $COSM $WRSC $INND $APE $AITX $TPIA pic.twitter.com/6yvzxLjUrv

— Ludlow Research (@LudlowResearch) December 6, 2022

[greenwillow]

No bid

[greenwillow]

lol nobody's buying anything from this dog chit company

[sweet crude]

Blockchain & machine learning for mental wellness

Ehave uses blockchain, artificial intelligence, and machine learning across our apps to improve our products and services. We develop and advance algorithms that build health profiles for search results, and create algorithms that advance healthcare, our speech-recognition systems allow patients to find their mental level through our apps. We’re also responsible for transporting billions of bytes of health records safely every day, developing applications & algorithms that make summarized data available to images and videos accessible to the blind, and creating magical visual experiences such as turning panorama photos into fully interactive 360 images. Our efforts form the glue between science, research, and improved patient health.

https://www.ehave.com/

[sweet crude]

Anxiety & depression could surge in 2023

With markets, economy, and just all the craziness going on there no doubt we should see real crisis in anxiety and depression.

This only increases EHVVF business outlook.

You get some traders who suffer from anxiety to buy stock that would send EHVVF running for so many suffer from that and depression.

[PennyPrestige]

Health data could be worth millions

This type of data biotech firms would want to purchase for clincal trials.

[sweet crude]

Ehave at Web3 Summit (new tweets)

Company is starting to show life with focus on health data and web3

@Ehaveinc1
#Web3 and #healthdata will allow patients to own, heal, and profit from their records. Ehave is working with industry leaders in Miami at the Miami Web 3 Summit @atlasweb3group on bringing Web3 technologies to health. #web3

https://twitter.com/Ehaveinc1

[sweet crude]

MetaHealthU = health data management

Building data sets up patient health that could be sold to biotech firms doing clinical trials for become big money for EHVVF

[sweet crude]

EHVVF Healthcare data management

Ehave $EHVVF

Healthcare Data Management would provide secure and anonymous data sets, utilizing #blockchain, for research firms in clinical trials for treatment of mental health disorders

#Anxiety #Depression

#biotech #ClinicalTrials #DataAnalytics #drugdiscovery #mentalhealth

Ehave $EHVVF

Healthcare Data Management would provide secure and anonymous data sets, utilizing #blockchain, for research firms in clinical trials for treatment of mental health disorders#Anxiety #Depression#biotech #ClinicalTrials #DataAnalytics #drugdiscovery #mentalhealth pic.twitter.com/EUsbM8Z3ty

— AI Venturetech (@aiventuretech) November 29, 2022

[sweet crude]

Ask .0065

starting to breakout

[PennyPrestige]

Nice! I got some of this and keeping my eyes open. Love deals!

[sweet crude]

EHVVF 10% discount for Thanksgiving!!!

@Ehaveinc1

10% off our top-selling Magic Mushrooms through FRIDAY ONLY!

Because we love you. 💕 And we love Magic Mushrooms#blackfriday #cybermonday pic.twitter.com/kitVNhgHOf

— Ehaveinc $EHVVF (@Ehaveinc1) November 22, 2022

[sweet crude]

Like to see break above 0055

That would confirm breakout above key trendline

[sweet crude]

Ask .006 now

[PennyPrestige]

Gonna grab some more myself!

[sweet crude]

Only 97,000 shares left @ .0055

[sweet crude]

Sell NFT data for biotech firms

@Ehaveinc1
$EHVVF - MetaHealthu

Utilizing #NFTs for health data and clinical researchers

Putting power back in the patient's hands!

$EHVVF - MetaHealthu

Utilizing #NFTs for health data and clinical researchers

Putting power back in the patient's hands! pic.twitter.com/QHosRZcjCf

— Ehaveinc $EHVVF (@Ehaveinc1) November 15, 2022

.....these NFTs could become huge data set big pharma would love to acquire

[sweet crude]

I just saw volume

New tweets and volume picking up.

Now like to see that spill over to $TPIA for that S-4 merger deal is moving closer to closing

[PennyPrestige]

Some great volume coming in today guys!!!

[PennyPrestige]

Ehave and NFTs smart moves!!!

$EHVVF - MetaHealthu

Utilizing #NFTs for health data and clinical researchers

Putting power back in the patient's hands! pic.twitter.com/QHosRZcjCf

— Ehaveinc $EHVVF (@Ehaveinc1) November 15, 2022

[sweet crude]

Tweet, signs of life (photos)

@Ehaveinc1
Ehave $EHVVF had great time attending, and bringing the CureDash van, to the #Microdose Wonderland conference in Miami early this month

#psychedelics #anxiety #despression #PTSD

Ehave $EHVVF had great time attending, and bringing the CureDash van, to the #Microdose Wonderland conference in Miami early this month#psychedelics #anxiety #despression #PTSD pic.twitter.com/9mqCaJtpHN

— Ehaveinc $EHVVF (@Ehaveinc1) November 15, 2022

[sweet crude]

TPIA moving up

Looks like 10Q filed, and with updated S-4 this is moving closer to NASDAQ listing
https://www.otcmarkets.com/stock/tpia/overview

[sweet crude]

Ehave tweet

@Ehaveinc1
Colorado passes #Prop122 to legalize the use of psilocybin mushrooms and other #psychedelics

Colorado passes #Prop122 to legalize the use of psilocybin mushrooms and other #psychedelicshttps://t.co/ElYZuqIVoY

— Ehaveinc $EHVVF (@Ehaveinc1) November 13, 2022

[sweet crude]

Prop122 Passes!!!

....many sites thought it passed yesterday but was so close counting went on till last night. NOW prop 122 has passed! Bullish for psychedelic sector.

Colorado becomes second state to legalize “magic mushrooms”

Proposition 122, which passed by an extremely thin margin, would allow healing centers where people could consume psilocybin mushrooms

Ten years after legalizing the use and sale of marijuana, Colorado became only the second state in the U.S. to legalize the use of psilocybin mushrooms.

The ballot measure, Proposition 122, squeaked across the finish line as ballots were tallied the day after Election Day, receiving 51% of the vote.

Proponents called it a “truly historic moment.”

“Colorado voters saw the benefit of regulated access to natural medicines, including psilocybin, so people with PTSD, terminal illness, depression, anxiety and other mental health issues can heal,” co-proponents, Kevin Matthews and Veronica Lightening Horse Perez said in emailed statement Wednesday evening.

https://coloradosun.com/2022/11/09/proposition-122-colorado-results-psilocybin-mushrooms-2/

[sweet crude]

Colorado passed prop 122 - Psychedelics legal

It was too close to call most of election night, but the results are in. Colorado voters spoke their minds on psychedelics legalization and approved Proposition 122, the Natural Medicine Health Act Initiative by two percentage points. The approved ballot immediately decriminalizes psilocybin, psilocin and mescaline (not derived from peyote), ibogaine and DMT.

https://www.benzinga.com/markets/cannabis/22/11/29628347/colorado-joins-oregon-will-decriminalize-and-regulate-psychedelics-begin-expungement-process

This is huge news for EHVVF going forward

[sweet crude]

TPIA - S-4 updated

This moving one step closer to approval and NASDAQ listing

https://www.sec.gov/Archives/edgar/data/1931373/000109690622002636/psly_s4a.htm

TPIA .125 x .18
https://www.otcmarkets.com/stock/tpia/quote

[PennyPrestige]

Tweet says news coming!

Ai Venturtech will be interviewing the team at Ehave $EHVVF and how they use #AI and #MachineLearning to help treat people suffering from mental health issues such as #anxiety #depression and #PTSD

Stay tuned for updates!https://t.co/zQVvMKFmzA

— AI Venturetech (@aiventuretech) November 4, 2022

[mars2063]

Pdg escrocs

[greenwillow]

Lol, dog chit

[greenwillow]

Dog chit

[sweet crude]

Positive Ketamine and games study - NPR

Computer games designed to boost self-esteem appear to prolong the antidepressant benefits of the mind-bending anesthetic ketamine.

A recent study of 154 people found that those who played games featuring smiling faces and positive messages remained free of depression up to three months after a ketamine infusion, a team reports in the American Journal of Psychiatry.

People who got ketamine alone tended to relapse after a week or two.

The results are important because "we need new approaches that help people get feeling better faster and help them stay feeling better," says Rebecca Price, an author of the study and an associate professor of psychiatry and psychology at the University of Pittsburgh.

https://www.npr.org/sections/health-shots/2022/10/31/1132371480/smiling-faces-might-help-the-drug-ketamine-keep-depression-at-bay

....I think along with KataDash EHVVF also has games to help people with mental health issues.

[PennyPrestige]

This agreement with TPIA is a huge step in the right direction. I'm holding!

https://finance.yahoo.com/news/ehave-announces-mycotopia-therapies-reaches-130000386.html

[PennyPrestige]

Interesting coverage here :

https://ludlowresearch.com/ehvvf-coverage-growing-mental-health-crisis-psychedelic/

[koolmc]

pos lol

[greenwillow]

lol, indeed!

EHVVF + TPIA =

Who needs help with the equation?

[koolmc]

lol greenwillow you still here?

[sweet crude]

VA expanding ketamine for Veterans

VA community clinics expand Ketamine treatment options for depression

The largest ketamine therapy provider in the U.S. has expanded its relationship with the Department of Veterans Affairs’ Community Care Network to provide more ketamine treatments for veterans suffering from a variety of depressive disorders.

https://www.militarytimes.com/off-duty/military-culture/2022/09/29/va-community-clinics-expand-ketamine-treatment-options-for-depression/

[sweet crude]

TPIA a steal at .22

Worth gamble if NASDAQ merger goes off at 1.50 to 2.00

[greenwillow]

Wow really pumptastic!!!

Dog chit + dog chit = Dog chit(s)

Tpia + ehvvf = ?

Need help solving?

[sweet crude]

SEC update on TPIA merger

https://www.sec.gov/Archives/edgar/data/1931373/000109690622002459/psly_425.htm

1. What is the status of the Transaction?

PSLY has filed a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in connection with its previously announced Transaction, pursuant to which PSLY will acquire Mycotopia and Ei.Ventures. The SEC is currently reviewing the Registration Statement and PSLY will address any comments from the SEC that it may receive in the upcoming weeks. Upon acceptance by the SEC of the responses, the Registration Statement will become effective. After the effective date of the Registration Statement, PSLY expects to apply for its common stock to be listed on the NASDAQ Capital Market under the symbol “PSLY”.

[sweet crude]

ask 005, super cheap with ketamine demand growing

Worse economy gets more people will seek out treatments like ketamine and psychedelics to deal with the stress.

[greenwillow]

Dog chit + dog chit = more dog chit

Tpia + ehvvf = ?

Need help solving?